Scientific Papers
NF1 Specific
Do hormonal contraceptives stimulate growth of neurofibromas? A survey on 59 NF1 patients.
Marge Lammert, Victor-Felix Mautner, and Lan Kluwe
Superficial Neurofibroma: A Lesion with Unique MRI Characteristics in Patients with Neurofibromatosis Type 1
Ruth Lim, Diego Jaramillo, Tina Young Poussaint, Yuchiao Chang and Bruce Korf.
Neurofibromatous neuropathy in neurofibromatosis 1 (NF1)
Ferner RE, Hughes RA, Hall SM, Upadhyaya M, Johnson MR.
Practical Genetics: Neurofibromatosis 1
Rosalie E Ferner, Department of Neurology, Guy’s and St Thomas’ Hospitals, London, UK
NF2 Specific
Neurofibromatosis Type 2 (NF2): A clinical and molecular view
D. Gareth R. Evans
Radiosurgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2: tumor control and hearing preservation
Phi JH, Kim DG, Chung HT, Lee J, Paek SH, Jung HW
Merlin Is a Potent Inhibitor of Glioma Growth
Lau YKI, Murray LB, Houshmandi SS, Xu Y, Gutmann DH, Yu Q
Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates
Mathieu D et al.
Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients
Scott R. Plotkin, M.D., Ph.D., Caroline C. O’Donnell, B.A., R.N., William T. Curry Jr., M.D., Catherine M. Bove, M.Ed., A.P.N.G., Mia MacCollin, M.D., and Fabio P. Nunes, M.D.
Participating in Research
People with NF play an important role in the development of new treatments of neurofibromatosis by participating in clinical trials. If you are interested in participating in a trial, please visit our page on the subject.
